CHI3L1 and neoplasm: Interestingly, CHI3L1 overexpression in the murine model was associated with increased expression and activation of anti-tumor T-cell-related genes, suggesting that CHI3L1-targeted therapy might synergize with immune checkpoint inhibitors [73] (Figure 1).